Pear Therapeutics: Funding, Investors & Team (Sep 2026)
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.
Pear Therapeutics has raised $145M across 2 funding rounds on record, the most recent a Post-IPO Equity of $125M announced in Dec 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Pear Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2021.
Pear Therapeutics Funding Rounds
Pear Therapeutics raised $20.0M in a Series D announced in Mar 2021.
9 months later, a Post-IPO Equity of $125M was announced in Dec 2021.
Pear Therapeutics Founders and Leadership Team
Contact details for the Pear Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Pear Therapeutics Funding Compared to Other Biotechnology Startups
Pear Therapeutics' latest round of $125M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pear Therapeutics in Biotechnology and Boston
Companies Similar to Pear Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Pear Therapeutics Funding FAQs
What does Pear Therapeutics do?
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.
How much funding has Pear Therapeutics raised?
Pear Therapeutics has raised $145M across 2 rounds on record. The most recent is a Post-IPO Equity of $125M announced in Dec 2021.
When did Pear Therapeutics last raise funding?
Pear Therapeutics' most recent funding round on record is a Post-IPO Equity of $125M, announced in Dec 2021.
Who is the CEO of Pear Therapeutics?
Corey McCann is listed as CEO at Pear Therapeutics.
Where is Pear Therapeutics headquartered?
Pear Therapeutics is based in Boston, Massachusetts, United States.
How many employees does Pear Therapeutics have?
Pear Therapeutics is in the 251-500 employee band.
How does Pear Therapeutics' funding compare to other Biotechnology startups?
Pear Therapeutics' latest round of $125M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Pear Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pear Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.